Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | LZM009 |
Trade Name | |
Synonyms | LZM-009|LZM 009 |
Drug Descriptions |
LZM009 is a monoclonal antibody that targets PD-1 (PDCD1) and inhibits binding of the PD-L1 (CD274) ligand, potentially resulting in enhanced anti-tumor immune response (NCI Drug Dictionary). |
DrugClasses | Immune Checkpoint Inhibitor 149 PD-L1/PD-1 antibody 121 |
CAS Registry Number | NA |
NCIT ID | C153149 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
LZM009 | LZM009 | 0 | 1 |